The consequences of the edge-effect in a commercial enzyme-linked immunosorbent assay (ELISA) for the diagnosis of Lyme neuroborreliosis.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
The consequences of the edge-effect in a commercial enzyme-linked immunosorbent assay (ELISA) for the diagnosis of Lyme neuroborreliosis.Published in
J Clin Microbiol 2021; 59(8):e0328020PMID
33980651ae974a485f413a2113503eed53cd6c53
10.1128/JCM.03280-20
Scopus Count
Collections
Related articles
- Retrospective Evaluation of Various Serological Assays and Multiple Parameters for Optimal Diagnosis of Lyme Neuroborreliosis in a Routine Clinical Setting.
- Authors: van Gorkom T, Voet W, van Arkel GHJ, Heron M, Hoeve-Bakker BJA, Notermans DW, Thijsen SFT, Kremer K
- Issue date: 2022 Jun 29
- Intrathecally produced IgG and IgM antibodies to recombinant VlsE, VlsE peptide, recombinant OspC and whole cell extracts in the diagnosis of Lyme neuroborreliosis.
- Authors: Stanek G, Lusa L, Ogrinc K, Markowicz M, Strle F
- Issue date: 2014 Apr
- Antibodies to decorin-binding protein B (DbpB) in the diagnosis of Lyme neuroborreliosis in children.
- Authors: Sillanpää H, Skogman BH, Sarvas H, Seppälä IJ, Lahdenne P
- Issue date: 2014 Nov
- Improvement of diagnostic approach to Lyme neuroborreliosis in children by using recombinant antigens in detection of intrathecally produced IgM/IgG.
- Authors: Krbková L, Bednářová J, Čermáková Z
- Issue date: 2016 Summer
- CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
- Authors: Markowicz M, Schötta AM, Kundi M, Bogovič P, Ogrinc K, Strle F, Stanek G
- Issue date: 2018 Jul